FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897845438> ?p ?o ?g. }

• W2897845438 abstract "Background Antiphospholipid antibodies (aPL) as pathogenic autoantibodies in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are supported by a number of clinical, ex vivo and animal studies. Nevertheless, aPL are not eliminated by corticosteroid administration or immunosuppression. Novel therapy targeting aPL production is currently unmet needs, in contrast, little is known on its pathological mechanism. Objectives This study aimed to clarify the mechanism of aPL production by lymphocyte subset analysis, genomic analysis and ex vivo experiments. Methods B cell and T cell subsets, a total of 21 subsets, were evaluated in peripheral blood mononuclear cells (PBMC) of 26 primary APS (PAPS), 18 SLE-associated APS (SLE/APS) patients and 10 healthy controls by flow cytometry. Twenty-one single nucleotide polymorphisms (SNP), which were shown to be associated with autoimmune or thrombotic diseases, were analysed in genomic DNA of those patients by TaqMan genotyping assay. Interferon (IFN) score was calculated based on the mRNA expression of Ly6e, Mx1, IFIT1 and IFIT3 in PBMC. To evaluate the aPL-producing capability of plasmablasts, PBMC obtained from APS patients were cultured following depletion of CD19 +CD20+or CD19+CD20 cells and the culture supernatants were applied to aPL measurements by enzyme-linked immunosorbent assay and cell assay using β2GPI/HLA-DR7 overexpressing HEK293T cells.1 Results In PAPS and SLE/APS patients, plasmablasts, Th2 cells and Th17 cells were increased while pre- and post- switched memory B cells, regulatory B cells and regulatory T cells were decreased compared to healthy controls. Genomic analysis revealed that the increase of plasmablasts (p=0.032) and the decrease of memory B cells (p=0.013) were more pronounced in patients with a risk allele of SNP in toll like receptor 7 (TLR7) gene (rs3853839). IFN score was significantly higher in the TLR7 SNP risk allele carriers, confirming the downstream signalling of TLR7 (p=0.029). Ex vivo experiments showed that aPL, including anti-cardiolipin/β2-glycoprotein I-HLA class II complexes -IgG and -IgM, were present in the culture supernatant of CD19 +CD20+depleted PBMC from APS patients, but not in that of CD19 +CD20 depleted cells. Conclusions Our data indicate an important role of plasmablasts in the production of aPL. Furthermore, plasmablast proliferation was associated with TLR 7 and type I IFN, suggesting a common pathophysiology in SLE and APS. Targeting plasmablasts might be a novel, immunological therapeutic approach in the treatment of APS. Reference [1] Tanimura K, et al. β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood2015. Disclosure of Interest None declared" @default.
• W2897845438 created "2018-10-26" @default.
• W2897845438 creator A5002718440 @default.
• W2897845438 creator A5003587098 @default.
• W2897845438 creator A5016009056 @default.
• W2897845438 creator A5021673902 @default.
• W2897845438 creator A5056838626 @default.
• W2897845438 creator A5061443644 @default.
• W2897845438 creator A5070300954 @default.
• W2897845438 creator A5073548467 @default.
• W2897845438 creator A5079071350 @default.
• W2897845438 date "2018-06-01" @default.
• W2897845438 modified "2023-09-24" @default.
• W2897845438 title "OP0356 Plasmablast proliferation is associated with toll like receptor 7 polymorphisms and upregulation of type i interferon, contributing to the antibody production in antiphospholipid syndrome" @default.
• W2897845438 doi "https://doi.org/10.1136/annrheumdis-2018-eular.2816" @default.
• W2897845438 hasPublicationYear "2018" @default.
• W2897845438 type Work @default.
• W2897845438 sameAs 2897845438 @default.
• W2897845438 citedByCount "0" @default.
• W2897845438 crossrefType "proceedings-article" @default.
• W2897845438 hasAuthorship W2897845438A5002718440 @default.
• W2897845438 hasAuthorship W2897845438A5003587098 @default.
• W2897845438 hasAuthorship W2897845438A5016009056 @default.
• W2897845438 hasAuthorship W2897845438A5021673902 @default.
• W2897845438 hasAuthorship W2897845438A5056838626 @default.
• W2897845438 hasAuthorship W2897845438A5061443644 @default.
• W2897845438 hasAuthorship W2897845438A5070300954 @default.
• W2897845438 hasAuthorship W2897845438A5073548467 @default.
• W2897845438 hasAuthorship W2897845438A5079071350 @default.
• W2897845438 hasBestOaLocation W28978454381 @default.
• W2897845438 hasConcept C137061746 @default.
• W2897845438 hasConcept C150903083 @default.
• W2897845438 hasConcept C159654299 @default.
• W2897845438 hasConcept C163764329 @default.
• W2897845438 hasConcept C202751555 @default.
• W2897845438 hasConcept C203014093 @default.
• W2897845438 hasConcept C207001950 @default.
• W2897845438 hasConcept C26291073 @default.
• W2897845438 hasConcept C2776090121 @default.
• W2897845438 hasConcept C2776874634 @default.
• W2897845438 hasConcept C2778957590 @default.
• W2897845438 hasConcept C2779053233 @default.
• W2897845438 hasConcept C55493867 @default.
• W2897845438 hasConcept C71924100 @default.
• W2897845438 hasConcept C86803240 @default.
• W2897845438 hasConcept C8891405 @default.
• W2897845438 hasConceptScore W2897845438C137061746 @default.
• W2897845438 hasConceptScore W2897845438C150903083 @default.
• W2897845438 hasConceptScore W2897845438C159654299 @default.
• W2897845438 hasConceptScore W2897845438C163764329 @default.
• W2897845438 hasConceptScore W2897845438C202751555 @default.
• W2897845438 hasConceptScore W2897845438C203014093 @default.
• W2897845438 hasConceptScore W2897845438C207001950 @default.
• W2897845438 hasConceptScore W2897845438C26291073 @default.
• W2897845438 hasConceptScore W2897845438C2776090121 @default.
• W2897845438 hasConceptScore W2897845438C2776874634 @default.
• W2897845438 hasConceptScore W2897845438C2778957590 @default.
• W2897845438 hasConceptScore W2897845438C2779053233 @default.
• W2897845438 hasConceptScore W2897845438C55493867 @default.
• W2897845438 hasConceptScore W2897845438C71924100 @default.
• W2897845438 hasConceptScore W2897845438C86803240 @default.
• W2897845438 hasConceptScore W2897845438C8891405 @default.
• W2897845438 hasLocation W28978454381 @default.
• W2897845438 hasOpenAccess W2897845438 @default.
• W2897845438 hasPrimaryLocation W28978454381 @default.
• W2897845438 hasRelatedWork W1608469865 @default.
• W2897845438 hasRelatedWork W1826436091 @default.
• W2897845438 hasRelatedWork W1965611395 @default.
• W2897845438 hasRelatedWork W2137552713 @default.
• W2897845438 hasRelatedWork W2145665764 @default.
• W2897845438 hasRelatedWork W2415306690 @default.
• W2897845438 hasRelatedWork W2525187825 @default.
• W2897845438 hasRelatedWork W2553749463 @default.
• W2897845438 hasRelatedWork W2734570768 @default.
• W2897845438 hasRelatedWork W2791629938 @default.
• W2897845438 hasRelatedWork W2897572558 @default.
• W2897845438 hasRelatedWork W2898814848 @default.
• W2897845438 hasRelatedWork W2921004331 @default.
• W2897845438 hasRelatedWork W2948814328 @default.
• W2897845438 hasRelatedWork W2970550124 @default.
• W2897845438 hasRelatedWork W3107799816 @default.
• W2897845438 hasRelatedWork W3126730711 @default.
• W2897845438 hasRelatedWork W3134697946 @default.
• W2897845438 hasRelatedWork W3138604854 @default.
• W2897845438 hasRelatedWork W3164102404 @default.
• W2897845438 isParatext "false" @default.
• W2897845438 isRetracted "false" @default.
• W2897845438 magId "2897845438" @default.
• W2897845438 workType "article" @default.